No Script

Please Wait...

Al-Ahed Telegram

Moderna To Apply for Emergency FDA Authorization for Coronavirus Vaccine

Moderna To Apply for Emergency FDA Authorization for Coronavirus Vaccine
folder_openUnited States access_time3 years ago
starAdd to favorites

By Staff, Agencies

The United States’ Moderna pharmaceutical giant said Monday it plans to apply for emergency use authorization from the US Food and Drug Administration for its COVID-19 vaccine.

In a statement, the company said that new data gathered over the massive Phase III trial of the vaccine put its effectiveness at 94.1 percent.

The estimate is based on the 196 confirmed COVID-19 infections among the 30,000 volunteers taking part in the trial.

The volunteers were given either the two-shot vaccine or a placebo; most of the infections -- 185 -- were registered among the latter, the company said.

The vaccine also appeared to have protected the participants from developing severe COVID-19 symptoms, the company added.

Out of 30 severe cases of coronavirus infection registered among the participants, none were among those who were inoculated.

"We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death,” Moderna CEO Stephane Bancel said.

Comments